Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP849631.RAbEHOGXbiL5JjBc6n5390Q4kFf4nAkFv_YSsWYBsy6h4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP849631.RAbEHOGXbiL5JjBc6n5390Q4kFf4nAkFv_YSsWYBsy6h4130_assertion type Assertion NP849631.RAbEHOGXbiL5JjBc6n5390Q4kFf4nAkFv_YSsWYBsy6h4130_head.
- NP849631.RAbEHOGXbiL5JjBc6n5390Q4kFf4nAkFv_YSsWYBsy6h4130_assertion wasGeneratedBy ECO_0000203 NP849631.RAbEHOGXbiL5JjBc6n5390Q4kFf4nAkFv_YSsWYBsy6h4130_provenance.
- NP849631.RAbEHOGXbiL5JjBc6n5390Q4kFf4nAkFv_YSsWYBsy6h4130_assertion wasDerivedFrom befree-2016 NP849631.RAbEHOGXbiL5JjBc6n5390Q4kFf4nAkFv_YSsWYBsy6h4130_provenance.
- NP849631.RAbEHOGXbiL5JjBc6n5390Q4kFf4nAkFv_YSsWYBsy6h4130_assertion SIO_000772 21040950 NP849631.RAbEHOGXbiL5JjBc6n5390Q4kFf4nAkFv_YSsWYBsy6h4130_provenance.
- NP849631.RAbEHOGXbiL5JjBc6n5390Q4kFf4nAkFv_YSsWYBsy6h4130_assertion evidence source_evidence_literature NP849631.RAbEHOGXbiL5JjBc6n5390Q4kFf4nAkFv_YSsWYBsy6h4130_provenance.
- NP849631.RAbEHOGXbiL5JjBc6n5390Q4kFf4nAkFv_YSsWYBsy6h4130_assertion description "[In conclusion, (i) constitutive activation of EGFR/Akt/mTOR pathway was present in defined subset of NSCLC; (ii) mTOR/S6K/rS6 axis is frequently activated in AC, and constitutively activated through Akt by EGFR mutation even in SCC; and (iii) mTOR and rS6 are possible determinants of nodal metastasis in SCC and AC, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP849631.RAbEHOGXbiL5JjBc6n5390Q4kFf4nAkFv_YSsWYBsy6h4130_provenance.